tibolone has been researched along with Uterine Hemorrhage in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.00) | 18.7374 |
| 1990's | 11 (27.50) | 18.2507 |
| 2000's | 21 (52.50) | 29.6817 |
| 2010's | 6 (15.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cancelo Hidalgo, MJ | 1 |
| Brito, LG; Candido Dos Reis, FJ; Ferriani, RA; Martins, WP; Moroni, RM; Nastri, CO; Vieira, CS | 1 |
| Cheng, J; Zhang, Z | 1 |
| Hadji, P; Hars, O; Kalder, M; Kauka, A; Kyvernitakis, I | 1 |
| Balduzzi, S; Basevi, V; Bassi, C; D'Amico, R; Formoso, G; Maestri, E; Magrini, N; Maltoni, S; Marata, AM; Perrone, E; Wilkinson, J | 1 |
| Agarwal, S; Hickey, M | 1 |
| Radowicki, S; Szlendak-Sauer, K; Wierzba, W | 1 |
| Birkhaeuser, MH; Davis, S; Mulder, RJ; Nathorst-Böös, J; Nijland, EA; Palacios, S; Schultz, WC; Stathopoulos, VM; van de Weijer, PW; von Mauw, E | 1 |
| Bai, WP; Chen, SL; Geng, L; Hu, LN; Liu, JL; Wang, SY; Zhang, ZL; Zheng, SR | 1 |
| Balduzzi, S; Basevi, V; Bassi, C; D'Amico, R; Formoso, G; Maestri, E; Magrini, N; Maltoni, S; Marata, AM; Perrone, E | 1 |
| Karakus, C; Simsek, T; Trak, B | 1 |
| Berglund, L; Christau, S; Hänggi, W; Helmond, F; Huber, J; Palacios, S; Sathanandan, SM | 1 |
| Bennink, HJ; Engelen, S; Helmond, FA; Landgren, MB | 1 |
| Bruce, D; Robinson, J; Rymer, J | 1 |
| Engelen, S; Helmond, FA; Landgren, MB | 1 |
| Khalil, AM; Nassar, AH; Seoud, MA; Usta, IM | 1 |
| Buchwalder, L; Kloosterboer, HJ; Krikun, G; Kuczynski, E; Lockwood, CJ; Schatz, F; Tang, C | 1 |
| Bae, DS; Choi, DS; Min, JA; Shin, SY; Yoon, BK | 1 |
| Helmond, FA; Landgren, BM; Langer, RD; Rymer, J | 1 |
| Archer, DF; den Hollander, W; Ferenczy, A; Gallagher, JC; Helmond, FA; Hendrix, S; Rymer, J; Skouby, S; Stathopoulos, V | 1 |
| Fogelman, I; Morris, EP; Robinson, J; Rymer, J | 1 |
| Sturdee, DW | 1 |
| Blum, A; Dieulangard, P; Trévoux, R | 1 |
| Chryssikopoulos, E; Cortes-Prieto, J; Eydam, F; Franchi, F; Kicovic, PM; Liukko, P; Luisi, M; Milojevic, S; Punnonen, R; Trévoux, R | 1 |
| Haverkorn, MJ; Meuwissen, JH; Wiegerinck, MA | 1 |
| Chapman, MG; Fogelman, I; Rymer, J | 1 |
| Bjarnason, K; Bjarnason, NH; Christiansen, C; Haarbo, J; Rosenquist, C | 1 |
| Akkad, A; al-Azzawi, F; Habiba, M; Hart, DM; Ramsay, J | 1 |
| Ginsburg, J; Prelevic, GM | 1 |
| Egarter, C; Fischl, F; Haidbauer, R; Huber, J; Leikermoser, R; Pusch, H; Putz, M | 1 |
| Altermatt, HJ; Bersinger, N; Birkhäuser, MH; Hänggi, W | 1 |
| Christau, S; Garre, K; Hammar, M; Nathorst-Böös, J; Rud, T | 1 |
| Morris, EP; Robinson, J; Rymer, JM; Wilson, PO | 1 |
| Coelingh Bennink, HJ; Dören, M; Holzgreve, W; Rübig, A | 1 |
| Bennink, HJ; Berning, B; Fauser, BC; van Kuijk, C | 1 |
| Moore, RA | 1 |
| Baylink, DJ; Freeman, R; Gallagher, JC; McClung, M | 1 |
| Malinova, M; Milchev, N; Pekhlivanov, B | 1 |
| Baracat, EC; Barbosa, IC; Giordano, MG; Haidar, MA; Marinho, RM; Menegocci, JC; Morais, KM; Tomaz, G; Wehba, S | 1 |
| Benhamou, CL; Fechtenbaum, J; Loiseau-Peres, S; Pelissier, C; Roux, C | 1 |
6 review(s) available for tibolone and Uterine Hemorrhage
| Article | Year |
|---|---|
[Hormonal treatments for hemorrhaging secondary to fibroids. An alternative or complement to surgery?].
Topics: Combined Modality Therapy; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogen Receptor Modulators; Estrogens; Female; Humans; Hysterectomy; Leiomyoma; Levonorgestrel; Norpregnenes; Progesterone; Progestins; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms | 2013 |
Add-back therapy with GnRH analogues for uterine fibroids.
Topics: Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Drug Therapy, Combination; Estriol; Female; Gonadotropin-Releasing Hormone; Humans; Isoflavones; Leiomyoma; Medroxyprogesterone; Norpregnenes; Quality of Life; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Uterine Hemorrhage; Uterine Neoplasms | 2015 |
Short-term and long-term effects of tibolone in postmenopausal women.
Topics: Aged; Breast Neoplasms; Dyspareunia; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Randomized Controlled Trials as Topic; Stroke; Sweating; Uterine Hemorrhage | 2016 |
Short and long term effects of tibolone in postmenopausal women.
Topics: Aged; Breast Neoplasms; Dyspareunia; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Stroke; Sweating; Uterine Hemorrhage | 2012 |
Endometrial safety and bleeding with HRT: what's new?
Topics: Endometrial Hyperplasia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Evidence-Based Medicine; Female; Humans; Norpregnenes; Progesterone Congeners; Uterine Hemorrhage; Women's Health | 2007 |
Livial: a review of clinical studies.
Topics: Affective Symptoms; Anabolic Agents; Bone Diseases; Breast Neoplasms; Climacteric; Coronary Disease; Endometriosis; Estrogen Replacement Therapy; Female; Humans; Libido; Norpregnenes; Postmenopause; Randomized Controlled Trials as Topic; Uterine Hemorrhage; Vaginal Diseases | 1999 |
23 trial(s) available for tibolone and Uterine Hemorrhage
| Article | Year |
|---|---|
Comparison of combined low-dose hormone therapy vs. tibolone in the prevention of bone loss.
Topics: Absorptiometry, Photon; Bone Density; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norpregnenes; Osteoporosis, Postmenopausal; Prospective Studies; Uterine Hemorrhage | 2016 |
[The influence of a tibolone therapy on endometrium in postmenopausal women].
Topics: Aged; Anabolic Agents; Endometrium; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Poland; Postmenopause; Treatment Outcome; Ultrasonography; Uterine Hemorrhage; Vagina | 2008 |
Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction.
Topics: Administration, Cutaneous; Aged; Breast; Double-Blind Method; Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Pain; Postmenopause; Sexual Dysfunction, Physiological; Uterine Hemorrhage | 2009 |
[Efficacy and safety of remifemin compared to tibolone for controlling of perimenopausal symptoms].
Topics: Administration, Oral; Adult; Cimicifuga; Double-Blind Method; Endometrium; Female; Hot Flashes; Humans; Middle Aged; Nervous System Diseases; Norpregnenes; Perimenopause; Phytotherapy; Plant Extracts; Uterine Hemorrhage | 2009 |
Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system.
Topics: Administration, Cutaneous; Aged; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Polyps; Postmenopause; Progesterone Congeners; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms | 2002 |
Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women.
Topics: Drug Combinations; Estrogen Receptor Modulators; Estrogens; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Middle Aged; Norpregnenes; Quality of Life; Uterine Hemorrhage | 2002 |
Dose-response analysis of effects of tibolone on climacteric symptoms.
Topics: Adult; Climacteric; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Middle Aged; Norpregnenes; Sweating; Uterine Hemorrhage | 2002 |
Long-term effects of tibolone on the endometrium as assessed by bleeding episodes, transvaginal scan and endometrial biopsy.
Topics: Anabolic Agents; Endometrium; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Prospective Studies; Surveys and Questionnaires; Treatment Outcome; Ultrasonography; Uterine Hemorrhage | 2004 |
Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day.
Topics: Climacteric; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Receptor Modulators; Europe; Female; Hot Flashes; Humans; Middle Aged; Norpregnenes; Sweating; Treatment Outcome; Uterine Hemorrhage | 2005 |
Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
Topics: Aged; Biopsy; Contraceptive Agents, Female; Double-Blind Method; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Endometrium; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Osteoporosis; Ultrasonography; Uterine Hemorrhage | 2006 |
Endometrial effects of tibolone.
Topics: Aged; Carcinoma; Cohort Studies; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Pain; Uterine Hemorrhage | 2007 |
Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
Topics: Adult; Antineoplastic Agents, Hormonal; Bone and Bones; Bone Density; Chemotherapy, Adjuvant; Cross-Over Studies; Double-Blind Method; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Middle Aged; Norpregnenes; Patient Compliance; Placebos; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms | 2008 |
Efficacy and safety of Org OD 14 in the treatment of climacteric complaints.
Topics: Atrophy; Climacteric; Endometrium; Female; Humans; Middle Aged; Norpregnenes; Patient Dropouts; Placebos; Sweating; Uterine Hemorrhage | 1983 |
The incidence of vaginal bleeding with tibolone treatment.
Topics: Anabolic Agents; Female; Humans; Menopause; Middle Aged; Norpregnenes; Prospective Studies; Uterine Hemorrhage | 1994 |
Tibolone: prevention of bone loss in late postmenopausal women.
Topics: Aged; Anabolic Agents; Bone and Bones; Bone Density; Double-Blind Method; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Placebos; Time Factors; Uterine Hemorrhage | 1996 |
Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints.
Topics: Climacteric; Dose-Response Relationship, Drug; Endometrium; Estrogens; Female; Humans; Incidence; Middle Aged; Norpregnenes; Progestins; Surveys and Questionnaires; Time Factors; Ultrasonography; Uterine Hemorrhage | 1996 |
Comparison of transvaginal ultrasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users.
Topics: Administration, Cutaneous; Administration, Oral; Anabolic Agents; Biopsy; Cohort Studies; Dydrogesterone; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Middle Aged; Norpregnenes; Postmenopause; Progesterone Congeners; Time Factors; Ultrasonography; Uterine Hemorrhage | 1997 |
A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms.
Topics: Anabolic Agents; Double-Blind Method; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Progesterone Congeners; Sexual Behavior; Sweating; Uterine Hemorrhage; Vaginal Diseases | 1998 |
Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
Topics: Aged; Anabolic Agents; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endosonography; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Incidence; Middle Aged; Norethindrone; Norpregnenes; Prospective Studies; Tablets; Uterine Hemorrhage; Vagina | 1999 |
Absent correlation between vaginal bleeding and oestradiol levels or endometrial morphology during tibolone use in early postmenopausal women.
Topics: Bone Density; Endometrium; Estradiol; Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Uterine Hemorrhage | 2000 |
Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies.
Topics: Aged; Body Weight; Bone Density; Double-Blind Method; Endometrium; Female; Humans; Lipids; Middle Aged; Norpregnenes; Osteocalcin; Osteoporosis, Postmenopausal; Uterine Hemorrhage | 2001 |
A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
Topics: Aged; Animals; Coitus; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Horses; Hot Flashes; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Uterine Hemorrhage; Weight Gain | 2002 |
Randomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone loss.
Topics: Androgen Antagonists; Bone Density; Breast; Calcium; Double-Blind Method; Estradiol; Female; Humans; Lumbar Vertebrae; Middle Aged; Norethindrone; Norpregnenes; Osteoporosis, Postmenopausal; Pain; Progesterone Congeners; Statistics, Nonparametric; Uterine Hemorrhage | 2002 |
11 other study(ies) available for tibolone and Uterine Hemorrhage
| Article | Year |
|---|---|
[Clinical and metabolic effects of drospirenone-estradiol versus tibolone in postmenopausal women:a comparative study].
Topics: Androstenes; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Female; Humans; Norpregnenes; Postmenopause; Retrospective Studies; Uterine Hemorrhage | 2015 |
Bleeding with menopausal hormone therapy.
Topics: Aged; Endometrium; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Metrorrhagia; Middle Aged; Norpregnenes; Polyps; Postmenopause; Uterine Hemorrhage | 2009 |
Endometrial adenocarcinoma after prolonged tibolone therapy.
Topics: Adenocarcinoma; Brachytherapy; Diagnosis, Differential; Drug Administration Schedule; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Uterine Hemorrhage | 2005 |
Tibolone and its metabolites enhance tissue factor and PAI-1 expression in human endometrial stromal cells: Evidence of progestogenic effects.
Topics: Androgen Antagonists; Cells, Cultured; Endometrium; Female; Gene Expression Regulation; Humans; Norpregnenes; Plasminogen Activator Inhibitor 1; Progestins; Receptors, Estrogen; Receptors, Progesterone; Stromal Cells; Thromboplastin; Uterine Hemorrhage | 2005 |
The incidence and characteristics of uterine bleeding during postoperative GnRH agonist treatment combined with tibolone add-back therapy in endometriosis patients of reproductive age.
Topics: Adult; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Incidence; Norpregnenes; Postoperative Complications; Retrospective Studies; Ultrasonography; Uterine Hemorrhage | 2007 |
Multicentre study of effects of Org OD 14 on endometrium, vaginal cytology and cervical mucus in post-menopausal and oophorectomized women.
Topics: Adult; Biopsy; Castration; Cell Division; Cervix Uteri; Drug Evaluation; Endometrium; Estrogens; Female; Humans; Lynestrenol; Menopause; Middle Aged; Mucus; Norpregnenes; Uterine Hemorrhage; Vagina; Vaginal Smears | 1984 |
Regression of endometrial thickness in combination with reduced withdrawal bleeding as a progestational effect of tibolone in postmenopausal women on oestrogen replacement therapy.
Topics: Adult; Aged; Endometrium; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Progestins; Uterine Hemorrhage | 1995 |
Immunohistochemical and hysteroscopic assessment of postmenopausal women with uterine bleeding whilst taking Tibolone.
Topics: Adult; Aged; Anabolic Agents; Case-Control Studies; Evaluation Studies as Topic; Female; Humans; Hysteroscopy; Immunohistochemistry; Middle Aged; Norpregnenes; Uterine Hemorrhage | 1996 |
Cause of vaginal bleeding in postmenopausal women taking tibolone.
Topics: Aged; Aged, 80 and over; Anabolic Agents; Carcinoma in Situ; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hysteroscopy; Leiomyoma; Middle Aged; Norpregnenes; Polyps; Postmenopause; Time Factors; Ultrasonography, Doppler; Uterine Hemorrhage; Uterine Neoplasms | 1996 |
Long term effects of tibolone on the genital tract in postmenopausal women.
Topics: Anabolic Agents; Case-Control Studies; Endometrium; Female; Genital Diseases, Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Uterine Diseases; Uterine Hemorrhage; Vaginal Diseases | 1999 |
[Our experience in the treatment of climacteric complaints with Livial (Organon)].
Topics: Anabolic Agents; Climacteric; Female; Hot Flashes; Humans; Nausea; Norpregnenes; Treatment Outcome; Uterine Hemorrhage | 2001 |